FR2398051A1 - Nouveau fragment du glucagon et ses derives - Google Patents

Nouveau fragment du glucagon et ses derives

Info

Publication number
FR2398051A1
FR2398051A1 FR7821686A FR7821686A FR2398051A1 FR 2398051 A1 FR2398051 A1 FR 2398051A1 FR 7821686 A FR7821686 A FR 7821686A FR 7821686 A FR7821686 A FR 7821686A FR 2398051 A1 FR2398051 A1 FR 2398051A1
Authority
FR
France
Prior art keywords
glucagon
new
derivatives
new fragment
gln
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7821686A
Other languages
English (en)
French (fr)
Other versions
FR2398051B1 (esLanguage
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP8855677A external-priority patent/JPS5424868A/ja
Priority claimed from JP11424277A external-priority patent/JPS5446776A/ja
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of FR2398051A1 publication Critical patent/FR2398051A1/fr
Application granted granted Critical
Publication of FR2398051B1 publication Critical patent/FR2398051B1/fr
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/605Glucagons

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FR7821686A 1977-07-22 1978-07-21 Nouveau fragment du glucagon et ses derives Granted FR2398051A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP8855677A JPS5424868A (en) 1977-07-22 1977-07-22 Novel glucagon fragment
JP11424277A JPS5446776A (en) 1977-09-21 1977-09-21 Novel peptide

Publications (2)

Publication Number Publication Date
FR2398051A1 true FR2398051A1 (fr) 1979-02-16
FR2398051B1 FR2398051B1 (esLanguage) 1983-09-16

Family

ID=26429925

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7821686A Granted FR2398051A1 (fr) 1977-07-22 1978-07-21 Nouveau fragment du glucagon et ses derives

Country Status (4)

Country Link
US (1) US4206199A (esLanguage)
DE (2) DE2858718C2 (esLanguage)
FR (1) FR2398051A1 (esLanguage)
GB (1) GB2002387B (esLanguage)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2467841A1 (fr) * 1979-10-16 1981-04-30 Toyo Jozo Kk Fragment de glucagon et son application a la preparation d'un anticorps specifique
FR2602679A1 (fr) * 1986-08-14 1988-02-19 Inst Nat Sante Rech Med Nouvelles compositions pharmaceutiques renfermant comme principe actif regulateur du mouvement des ions calcium un fragment du glucagon, et preparation d'un tel fragment

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5539702A (en) * 1978-08-30 1980-03-19 Takeda Chem Ind Ltd Method of measuring enzyme immunity of pancreas glucagon
JPS56163456A (en) * 1980-05-21 1981-12-16 Otsuka Pharmaceut Co Ltd Preparation of antigen
US4423034A (en) * 1980-10-16 1983-12-27 Toyo Jozo Kabushiki Kaisha Process for the preparation of antibodies
US5693741A (en) 1988-03-15 1997-12-02 The Boeing Company Liquid molding compounds
US4430326A (en) 1981-12-22 1984-02-07 University Patents, Inc. Method of diminishing glucose levels resulting from endogenous glucagon
GB2160312B (en) * 1984-04-13 1987-09-16 South African Inventions Adjuvant for immunisation
US5089390A (en) * 1987-09-04 1992-02-18 Syntex (U.S.A.) Inc. 2-methyl-4-hexene- and 2-methyl-4-heptene-1,2-diol derivatives
US7601691B2 (en) 1999-05-17 2009-10-13 Conjuchem Biotechnologies Inc. Anti-obesity agents
PT1180121E (pt) * 1999-05-17 2004-03-31 Conjuchem Inc Peptidos insulinotropicos de longa duracao
US20040266673A1 (en) * 2002-07-31 2004-12-30 Peter Bakis Long lasting natriuretic peptide derivatives
US6887470B1 (en) 1999-09-10 2005-05-03 Conjuchem, Inc. Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components
JP3974619B2 (ja) * 2003-01-10 2007-09-12 株式会社新潟ティーエルオー 遺伝子治療用ベクター及び該遺伝子治療用ベクターを投与された哺乳動物中又は培養細胞中の目的タンパク質の定量方法
CA2564031A1 (en) * 2004-04-23 2005-11-03 Conjuchem Biotechnologies Inc. Method for the purification of albumin conjugates
US8039432B2 (en) * 2005-11-09 2011-10-18 Conjuchem, Llc Method of treatment of diabetes and/or obesity with reduced nausea side effect
CN101384623B (zh) * 2005-12-22 2013-07-24 常山凯捷健生物药物研发(河北)有限公司 白蛋白与治疗剂的预成型偶联物的制备方法
US20090099074A1 (en) * 2007-01-10 2009-04-16 Conjuchem Biotechnologies Inc. Modulating food intake
BR112017005110A2 (pt) 2014-09-16 2018-01-23 Regeneron Pharma anticorpo monoclonal isolado ou fragmento de ligação ao antígeno do mesmo, molécula isolada de ácido nucleico, composição farmacêutica, e, método para diminuir níveis de glicose no sangue ou para tratar uma condição ou doença.
CA3034777A1 (en) 2016-08-30 2018-03-08 Regeneron Pharmaceuticals, Inc. Methods of treating severe insulin resistance by interfering with glucagon receptor signaling
US20190248888A1 (en) 2016-10-20 2019-08-15 Regeneron Pharmaceuticals, Inc. Methods of lowering blood glucose levels
MX2020002057A (es) 2017-08-22 2020-07-13 Regeneron Pharma Metodos para tratar trastornos del ciclo de la urea mediante interferencia con la señalizacion del receptor del glucagon.

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1232040A (esLanguage) * 1967-08-19 1971-05-19
US3979506A (en) * 1974-10-11 1976-09-07 Pierce Chemical Company Radioactive compounds for labeling proteins

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1643345C3 (de) * 1967-08-19 1975-09-25 Hoechst Ag, 6000 Frankfurt Glucagonderivat und Verfahren zur Herstellung von Glucagon

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1232040A (esLanguage) * 1967-08-19 1971-05-19
US3979506A (en) * 1974-10-11 1976-09-07 Pierce Chemical Company Radioactive compounds for labeling proteins

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
EXBK/67 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2467841A1 (fr) * 1979-10-16 1981-04-30 Toyo Jozo Kk Fragment de glucagon et son application a la preparation d'un anticorps specifique
FR2602679A1 (fr) * 1986-08-14 1988-02-19 Inst Nat Sante Rech Med Nouvelles compositions pharmaceutiques renfermant comme principe actif regulateur du mouvement des ions calcium un fragment du glucagon, et preparation d'un tel fragment
WO1988001174A1 (fr) * 1986-08-14 1988-02-25 Institut National De La Sante Et De La Recherche M Un fragment de glucagon regulateur du mouvement des ions calcium

Also Published As

Publication number Publication date
DE2832090A1 (de) 1979-02-08
US4206199A (en) 1980-06-03
GB2002387B (en) 1982-02-10
DE2858718C2 (esLanguage) 1989-07-06
FR2398051B1 (esLanguage) 1983-09-16
GB2002387A (en) 1979-02-21
DE2832090C2 (esLanguage) 1989-07-20

Similar Documents

Publication Publication Date Title
FR2398051A1 (fr) Nouveau fragment du glucagon et ses derives
GB1527562A (en) Substituted-methyl-11-cyano-9,10-dihydroethanoanthracene-11-carboxylates useful as intermediates
FR2385693A1 (fr) Derives d'acetamide utiles notamment en therapeutique
FR2364198A1 (fr) Nouveaux produits a action herbicide, derives d'acides phenoxyvaleriques
BG34614A3 (bg) Метод за получаване на производни на пеницилановата киселина
FR2384751A1 (fr) Nouveaux derives de la taurine a activite neuro-musculaire renforcee
SE7614201L (sv) Sett att framstella ftalaner
BG29132A3 (en) Method of obtaining of cyclohexan derivatives
GB1167734A (en) Substituted Salicylamides and Germicide Compositions made therefrom
FR2358385A1 (fr) Derives de l'anilide benzoique et fongicides contenant ces derives
FR2275210A1 (fr) Nouveaux derives de benzimidazolinone
BE862210A (fr) Produit electrophotographique, a sensibilite amelioree, contenant un derive de l'aniline
FR2358406A1 (fr) Derives d'acides 5-aroyl-1,2-dihydro-3h-pyrrolo (1,2-a)pyrrole-1-carboxyliques, leur obtention et leur application a titre de medicament
SE7909916L (sv) Beta,gamma-dihydropolyprenylalkoholer och farmaceutiska kompositioner innehallande desamma
GB1268951A (en) Phenoxy-amines
GB1514657A (en) Substituted acetic acid esters processes for producing them and compositions containing them
FR2378802A1 (fr) Nouveaux polystyrenes modifies et leur application a la catalyse de la transformation d'isocyanates en carbodiimides
ES454085A1 (es) Procedimiento para la preparacion de n-(r-tetrahidrofurfu- ril)-noroximorfona y n-(s-tetrahidrofurfuril)-noroximorfona nuevas.
FR2355830A1 (fr) Nouveaux derives de 6-7-benzomorphane, leur obtention et composition pharmaceutique les contenant
BG48333A3 (en) Method for preparing of 2, 2- dimethyl cyclopropane carbonic acid derivatives
FR2376846A1 (fr) Nouveaux derives de la piperidine
FR2368277A1 (fr) Nouveaux derives hydrogenes de l'isoquinoleine, ayant une activite vasoactive et spasmolytique
FR2430943A1 (fr) Nouveaux derives disulfures
FR2443464A1 (fr) Derives d'acides thiadiazole-1,3,4 carboxyliques-2 et produits fongicides et nematicides qui en contiennent
FR2378518A1 (fr) Nouveaux medicaments a base de derives de tetrahydrodibenzopyranne

Legal Events

Date Code Title Description
ST Notification of lapse